Bloomberg Law tracks recent federal government administrative actions and warnings directed toward pharmaceutical and life sciences entities.
Jacobs Pills, Inc.
- Issuing Office: Food and Drug Administration, Division of Pharmaceutical Quality Operations
- Recipient: Philip Altman (supervising pharmacist)
- Date: May 31, 2018 (posted July 3)
- Inspection of facility in Elmsford, N.Y., Feb. 22-28, 2017
Alleged Infractions
- Company does not have valid prescriptions for some of the drugs it produces.
- Some drugs at the facility are compounded using melatonin and domperidone, which aren’t permissible under FDA regulations for compounded drugs.
- Company uses ingredients that don’t comply with identity, strength, quality, and purity standards. ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.